National Bank of Canada
HRMY icon

National Bank of Canada’s Harmony Biosciences HRMY Stock Holding History

National Bank of Canada’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,425
Closed -$128K – 3071
2025
Q4 		$128K Buy
3,425
+1,964
+134% +$64.6K ﹤0.01% 1709
2025
Q3 		$40.2K Buy
+1,461
New +$50.3K ﹤0.01% 1988

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

National Bank of Canada's HRMY Position: Q1 2026 in Review

National Bank of Canada sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 3,425 shares — an estimated $128K sold.

National Bank of Canada first reported a position in HRMY in Q3 2025 and held it in 2 quarters. The position peaked at $128K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • National Bank of Canada reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 3,425 Harmony Biosciences shares in Q1 2026, an estimated $128K.
  • National Bank of Canada first reported a position in Harmony Biosciences in Q3 2025 and held it in 2 quarters.
  • National Bank of Canada's Harmony Biosciences position peaked at $128K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.